VECTURA GROUP LS -,000271

VECTURA GROUP LS -,000271

Share · GB00BKM2MW97 · A2PTCY (XLON)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of VECTURA GROUP LS -,000271
No Price
Invested Funds

The following funds have invested in VECTURA GROUP LS -,000271:

Fund
iShares MSCI UK Small Cap UCITS ETF GBP (Acc)
Vol. in million
1.334,91
Percentage (%)
0,23 %
Fund
iShares FTSE 250 UCITS ETF GBP (Dist)
Vol. in million
3.391,34
Percentage (%)
0,22 %
Company Profile for VECTURA GROUP LS -,000271 Share
Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees. The firm's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.

Company Data

Name VECTURA GROUP LS -,000271
Company Vectura Group plc
Website http://www.vectura.com
Primary Exchange XLON London
WKN A2PTCY
ISIN GB00BKM2MW97
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO William Downie
Country United Kingdom
Currency GBP
Employees 0,5 T
Address Unit 1, Prospect West, Bumpers Way, Chippenham
IPO Date 2004-07-02
Dividends from 'VECTURA GROUP LS -,000271'
Ex-Date Dividend per Share
01.06.2021 19,00 GBX
14.10.2019 5,00 GBX

Stock Splits

Date Split
01.06.2021 5:6
14.10.2019 12:13

Ticker Symbols

Name Symbol
London VEC.L
More Shares
Investors who hold VECTURA GROUP LS -,000271 also have the following shares in their portfolio:
BSK 1818     PF.S.565
BSK 1818 PF.S.565 Bond
Norddeutsche Landesbank -GZ- EO-IHS 23(30)
Norddeutsche Landesbank -GZ- EO-IHS 23(30) Unbekannt